Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Curanex Pharmaceuticals Inc

NASDAQ: CURX · Life Sciences · 2 alerts · CIK 2025942

Share price
$4.64Close, Nov 16
Market cap
$7.27M
Shares outstanding
1.57MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Curanex Pharmaceuticals Inc filings on SEC EDGAR ↗

1:41 PM ET 10-Q
Financial Results

Curanex Pharmaceuticals Q3 2026 Results: Net Loss of $2.82M, Loss Widens

Curanex Pharmaceuticals Inc reported a net loss of $9.26 million for the nine months ended September 30, 2026, a significant increase from the $1.15 million loss in the prior year period, primarily driven by a surge in Research & Development expenses. The company's cash position decreased to $1.58 million from $4.97 million at the start of the year, reflecting ongoing operational burn as it develops botanical drugs for inflammatory diseases.

Key figure
Net loss $2.82M

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.